Picture of CLS Holdings logo

CLI CLS Holdings News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsAdventurousSmall CapValue Trap

REG - CLS Holdings PLC - CLS leases over 8,900 sqm in Hamburg, Germany

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240904:nRSD7615Ca&default-theme=true

RNS Number : 7615C  CLS Holdings PLC  04 September 2024

 

 

 

 

 

 

 

 

 

 

PRESS RELEASE

 

 

Release date:                4 September 2024

Embargoed until:           07:00 am

 

CLS Holdings plc ("CLS" or the "Group")

CLS leases over 8,900 sqm in Hamburg, Germany

 

CLS announces it has let 8,939 sqm (96,219 sq. ft) at Fangdieckstrasse 75 in
Hamburg to the Hamburg Institut für Pathologie und Hämatopathologie (HPH).

 

The HPH Institute, which specialises in the diagnosis of haematological
diseases, has extended its existing lease of 5,628 sqm (60,579 sq. ft) of
office and laboratory space until 2035 and has leased an additional 3,311 sqm
(35,639 sq. ft) of office and production space in the property. The HPH
Institute will move into the additional space from September 2024, following
the current occupier's lease surrender, meaning the property will remain fully
let.

 

Fangdieckstrasse 75 was acquired by CLS in 2007 and has since been fully
refurbished and successfully repositioned as a science and healthcare hub. The
multi-tenant property has 13,092 sqm (140,921 Sq. ft) and offers a mix of
office, light industrial, and laboratory space.

 

Located close to the 'Science City Hamburg Bahrenfeld' area of Hamburg,
occupied by science and technology start-ups, the property is well connected
to major transport links.

 

Fredrik Widlund, Chief Executive Officer of CLS, commented:

 

"We are thrilled that HPH has not only extended their existing lease for over
10 years but has also chosen to lease additional space in Fangdieckstrasse 75.
Hamburg-Bahrenfeld is an up-and-coming commercial area and CLS has
successfully repositioned the property as an attractive location for science
and technology organisations, and demand from occupiers in this sector remains
high."

 

-ENDS-

 

 

 

For further information, please contact:

 

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com (http://www.clsholdings.com)

Fredrik Widlund, Chief Executive Officer

Andrew Kirkman, Chief Financial Officer

+44 (0)20 7582 7766

 

Media Contact:

 

Edelman Smithfield (Financial PR)

Alex Simmons

+44 7970 174 353

Hastings Tarrant

+44 7813 407 665

cls@edelmansmithfield.com (mailto:cls@edelmansmithfield.com)

 

Broker Contacts:

 

Panmure Liberum

Jamie Richards

David Watkins

+44 (0)20 3100 2000

 

Berenberg

Matthew Armitt

Richard Bootle

+44 (0) 203 207 7800

 

Registered in England No. 2714781. Registered Office as above

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUOUVRSAUKRAR

Recent news on CLS Holdings

See all news